Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors

被引:23
|
作者
Marasini, Bishnu P. [1 ]
Rahim, Fazal [2 ]
Perveen, Shahnaz [3 ]
Karim, Aneela [2 ]
Khan, Khalid Mohammed [2 ]
Atta-ur-Rahman [1 ]
Choudhary, M. Iqbal [1 ,4 ]
机构
[1] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan
[2] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi 75270, Pakistan
[3] Shahrah E Dr Salimuzzaman Siddiqui, PCSIR Labs Complex, Karachi 75280, Pakistan
[4] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 214421, Saudi Arabia
关键词
Benzoxazinone; alpha-Chymotrypsin inhibition; Serine protease; Cytotoxicity; 3T3 cell line; C1R SERINE-PROTEASE; CHRONIC-PANCREATITIS; 4H-3,1-BENZOXAZIN-4-ONES; ENZYME;
D O I
10.1016/j.bioorg.2017.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of benzoxazinones 1-28 were synthesized via reaction of anthranilic acid with various substituted benzoyl chlorides in the presence of triethylamine in chloroform. Compounds 1-18 showed a good inhibition of a-chymotrypsin with IC50 +/- SEM values between 6.5 and 341.1 mu M. Preliminary structure-activity relationships studies indicated that the presence of substituents on benzene ring reduces the inhibitory potential of benzoxazinone. Also the increased inhibitory potential due to fluoro group at phenyl substituent was observed followed by chloro and bromo substituents. Compounds with strong electron donating or withdrawing groups on phenyl substituent, showed a good inhibitory potential at ortho > meta > para position. Kinetics studies showed diverse types of inhibition, except uncompetitive-type inhibition. The Ki values ranged between 4.7 and 341.2 mu M. Interestingly, most of these compounds were non-cytotoxic to 3T3 cell line at 30 mu M, except compounds 6, 14 and 15. Competitive inhibitors of chymotrypsin are like to inhibit other a-chymotrypsin-like serine proteases due to structural and functional similarities between them. The inhibitors identified during the current study deserve to be further studied for their therapeutic potential against abnormalities mediated by chymotrypsin or other serine protease. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:210 / 221
页数:12
相关论文
共 50 条
  • [21] Synthesis and structure-activity relationships of novel warfarin derivatives
    Gebauer, Markus
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (06) : 2414 - 2420
  • [22] Synthesis of pironetin and related analogs: Studies on structure-activity relationships as tubulin assembly inhibitors
    Watanabe, H
    Watanabe, H
    Usui, T
    Kondoh, M
    Osada, H
    Kitahara, T
    JOURNAL OF ANTIBIOTICS, 2000, 53 (05): : 540 - 545
  • [23] Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors
    Giampietro, Letizia
    Gallorini, Marialucia
    Gambacorta, Nicola
    Ammazzalorso, Alessandra
    De Filippis, Barbara
    Della Valle, Alice
    Fantacuzzi, Marialuigia
    Maccallini, Cristina
    Mollica, Adriano
    Cataldi, Amelia
    Nicolotti, Orazio
    Amoroso, Rosa
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 224
  • [24] Synthesis and structure-activity relationships of ticlopidine derivatives and analogs as inhibitors of ectonucleotidase CD39
    Bi, Chunyang
    Schaekel, Laura
    Mirza, Salahuddin
    Sylvester, Katharina
    Pelletier, Julie
    Lee, Sang -Yong
    Pillaiyar, Thanigaimalai
    Sevigny, Jean
    Mueller, Christa E.
    BIOORGANIC CHEMISTRY, 2023, 135
  • [25] New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: Synthesis and analysis of structure-activity relationships
    Saify, Zafar Saied
    Azim, M. Kamran
    Ahmad, Waseem
    Nisa, Mehrun
    Goldberg, Daniel E.
    Hussain, Shaheen A.
    Akhtar, Shamim
    Akram, Arfa
    Arayne, Arshad
    Oksman, Anna
    Khan, Ishtiaq A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1282 - 1286
  • [26] Structure-activity relationships(SAR) studies of CamK II inhibitors
    Kieres, Karolina
    Sala, Marina
    Monterrey, Gomez Isabel
    Bertamino, Alessia
    D'Ursi, Annamaria
    Ilario, Maddalena
    Grieco, Paolo
    Novellino, Ettore
    Campiglia, Pietro
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 87 - 87
  • [27] Indole derivatives (2010-2020) as versatile tubulin inhibitors: synthesis and structure-activity relationships
    Naaz, Fatima
    Neha, Kumari
    Haider, Md Rafi
    Shafi, Syed
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (20) : 1795 - 1828
  • [28] Synthesis, Structure-Activity Relationships, and Parasitological Profiling of Brussonol Derivatives as New Plasmodium falciparum Inhibitors
    Barbosa, Camila S.
    Ahmad, Anees
    Maluf, Sarah El Chamy
    Moura, Igor M. R.
    Souza, Guilherme E.
    Guerra, Giovanna A. H.
    Barros, Roberto R. Moraes
    Gazarini, Marcos L.
    Aguiar, Anna C. C.
    Burtoloso, Antonio C. B.
    Guido, Rafael V. C.
    PHARMACEUTICALS, 2022, 15 (07)
  • [29] Synthesis and structure-activity relationships of phenoxypyridine derivatives as novel inhibitors of the sodium-calcium exchanger
    Kuramochi, T
    Kakefuda, A
    Yamada, H
    Sato, I
    Taguchi, T
    Sakamoto, S
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (19) : 5039 - 5056
  • [30] Design, Synthesis and Structure-Activity Relationships of Novel Diaryl Urea Derivatives as Potential EGFR Inhibitors
    Jiang, Nan
    Bu, Yanxin
    Wang, Yu
    Nie, Minhua
    Zhang, Dajun
    Zhai, Xin
    MOLECULES, 2016, 21 (11)